Research output per year
Research output per year
Fingerprint
Dive into the research topics where Marjolein van der Poel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
-
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS
de Jonge, A. V., Duetz, C., Bruins, W. S. C., Korst, C. L. B. M., Rentenaar, R., Cosovic, M., Eken, M., Twickler, I., Nijland, M., van der Poel, M. W. M., de Heer, K., Klerk, C. P. W., Strobbe, L., Oosterveld, M., Boersma, R., Koene, H. R., Roemer, M. G. M., van Werkhoven, E., Chamuleau, M. E. D. & Mutis, T., 12 Mar 2024, In: Blood advances. 8, 5, p. 1094-1104 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study
Jain, T., Estrada-Merly, N., Salas, M. Q., Kim, S., DeVos, J. D., Chen, M., Fang, X., Kumar, R., Andrade-Campos, M., Elmariah, H., Agrawal, V., Aljurf, M., Bacher, U., Badar, T., Badawy, S. M., Ballen, K. K., Beitinjaneh, A., Bhatt, V. R., Bredeson, C. N. & DeFilipp, Z. & 31 others, , 27 Aug 2024, In: Blood advances. 8, 16, p. 4281-4293 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Spanjaart, A. M., Ljungman, P., Tridello, G., Schwartz, J., Martinez-Cibrian, N., Barba, P., Kwon, M., Lopez-Corral, L., Martinez-Lopez, J., Ferra, C., Di Blasi, R., Ghesquieres, H., Mutsaers, P., Calkoen, F., Jak, M., van Doesum, J., Vermaat, J. S. P., van der Poel, M., Maertens, J. & Gambella, M. & 23 others, , Sept 2024, In: Leukemia. 38, 9, p. 1985-1991 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands
Meeuwes, F. O., Brink, M., Plattel, W., Van der Poel, M. W. M., Kersten, M. J., Wondergem, M., Böhmer, L., Woei-A-Jin, F. J. S. H., Visser, O., Oostvogels, R., Jansen, P. M., Neelis, K. J., Crijns, A. P. G., Daniëls, L. A., Snijders, T. J. F., Vermaat, J. S. P., Huls, G. A. & Nijland, M., 1 Apr 2024, In: Haematologica. 109, 4, p. 1163-1170 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final Results of the HOVON 105 / ALLG NHL 24 Study
Bromberg, J. E. C., Issa, S., van der Holt, B., van der Meulen, M., Dirven, L., Minnema, M. C., Seute, T., Durian, M., Cull, G., van der Poel, M. W. M., Stevens, W. B. C., Zijlstra, J. M., Brandsma, D., Nijland, M., Mason, K. D., Beeker, A., Abrahamse-Testroote, M. C. J., van den Bent, M. J., de Jong, D. & Doorduijn, J. K., 1 Apr 2024, In: Neuro-oncology. 26, 4, p. 724-734 11 p., noad224.Research output: Contribution to journal › Article › Academic › peer-review
Open Access